Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients

American Journal of Medicine

Volumn 100, Issue 4, 1996, Pages 412-417

  Nathan, David M ^a   Dunn, Frederick L ^b   Bruch, John ^b   McKitrick, Charles ^a   Larkin, Mary ^a   Haggan, Coral ^a   Lavin Tompkins, Jodi ^b   Norman, Dennis ^a   Rogers, David ^a   Simon, Deborah ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE CONTROL; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN METABOLISM; INSULIN PUMP; INTERMETHOD COMPARISON; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; EATING; FEMALE; HUMANS; HYPOGLYCEMIA; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; INSULIN; LONGITUDINAL STUDIES; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PSYCHOMOTOR PERFORMANCE;

EID: 0030007999     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)89516-2     Document Type: Article

References (27)

1. Nathan DM. The modern management of insulin-dependent diabetes mellitus. Med Clin North Am. 1988;72:1365-1378.
2. The DCCT Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complication in insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial. NEJM. 1993;329:978-986.
3. Saudek CD, Selam JL, Pitt HA, et al. A feasibility trial with the programmable implantable medication system for insulin delivery. NEJM. 1989;321:574-579.
4. DCCT Research Group. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med. 1991;90:450-459.
5. Selam J-L, Micossi P, Dunn FL, et al. Clinical trial of programmable implantable insulin pump for type I diabetes. Diabetes Care. 1992;15 877-885.
6. DCCT Research Group. Diabetes Control and Complications Trial (DCCT) Update. Diabetes Care. 1990;13:427-433.
7. Perlman K, Ehrlich RM, Filler RM, Albisser AM. Waveform requirements for metabolic normalization with continuous intravenous insulin delivery in man. Diabetes. 1981;30:710-717.
8. Smith A. The symbol digit modalities test. Learn Disord. 1968;3:61-81.
9. Lezak MD. Neuropsychological Assessment. 2nd ed. New York: Oxford University Press, 1983.
10. Ryan CM, Atchison J, Puczynski S, et al. Mild hypoglycemia associated with deterioration of mental efficiency in children with insulin dependent diabetes mellitus. J Pediatr. 1990;117:32-38.
11. Widom B, Simonson DC. Glycemic control and neuropsychologic function during hypoglycemia in patients with insulin dependent diabetes mellitus. Ann Intern Med. 1990;112:904-912.
12. Cox DJ, Gonder-Frederick LA, Schroeder DB, et al. Disruptive effects of acute hypoglycemia on speed of cognitive and motor performance. Diabetes Care. 1993;16:1391-1393.
13. 1 as measured by liquid chromatography or electrophoresis. Clin Chem. 1981;27:1261-1263.
14. Rudkowsi R, Gabriel A. The effect of immediate polyethylene glycol precipitation on free insulin measurements in diabetic patients with insulin antibodies. Diabetes. 1986;35:253-257.
15. Kritz H, Hagmuller G, Lovett R, Irsigler K. Implanted constant basal rate insulin infusion devices for type 1 (insulin-dependent) diabetic patients. Diabetologia. 1983;25:78-81.
16. Schade DS, Eaton RP, Friedman N, Spencer W. The intravenous, intraperitoneal, and subcutaneous routes of insulin delivery in diabetic men. Diabetes. 1979;28:1069-1072.
17. Blackshear PJ, Rohde TD, Grotting JC, et al. Control of blood glucose in experimental diabetes by means of a totally implantable insulin infusion device. Diabetes. 1979;28:634-639.
18. Shahshahani MN, Kitabchi AE. Glucose lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients. J Clin Endocrinol Metab. 1978;47:34-40.
19. Kinmonth AL, Baum JD. Timing of pre-breakfast insulin injection and postprandial metabolic control in diabetic children. BMJ. 1980;604-606.
20. Dimitriadis GD, Gerich JE. Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care. 1983;6:374-377.
21. Eaton RP, Spencer W, Schade DS, et al. Diabetic glucose control: matching plasma insulin concentrations to dietary and stress hyperglycemia. Diabetes Care. 1978;1:40-45.
22. Spraul M, Chantelau E, Koumoulidou J, Berger M. Subcutaneous or nonsubcutaneous injection of insulin. Diabetes Care. 1988;9:733-736.
23. Dillon RS. Improved serum insulin profiles in diabetic individuals who massaged their insulin injection sites. Diabetes Care. 1983;6:399-401.
24. Taylor R, Home PD, Alberti KGMM. Plasma-free insulin profiles after administration of insulin by jet and conventional syringe injection. Diabetes Care. 1981;4:377-379.
25. Moses AC, Gordon GS, Carey MC, Flier JS. Insulin administered intranasally as an insulin-bile salt aerosol. Diabetes. 1983;21:1040-1047.
26. B28) on meal-related plasma glucose excursions in type I diabetic subjects. Diabetes Care. 1991;14:571-577.
27. Brange J, Owens DR, Kang S, Volund A. Monomeric insulins and their experimental and clinical implications. Diabetes Care. 1990;13:923-954.